Terazosin
- Product NDC
- 71610-715
- 11-digit product format
- 716100715
- Labeler code
- 71610
- Product ID
- 71610-715_02e1512f-a37e-4a25-82a0-18d8b1af9193
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA075317
- Marketing category
- ANDA
- Marketing start
- 2004-12-20
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| D32S14F082 | TERAZOSIN HYDROCHLORIDE | 70024-40-7 | TERAZOSIN HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71610-715-60 | 71610071560 | 90 CAPSULE in 1 BOTTLE (71610-715-60) | 90 capsule | 2023-06-14 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| TERAZOSIN CAPSULES, USP | Aphena Pharma Solutions - Tennessee, LLC | 2023-06-15 | HUMAN PRESCRIPTION DRUG LABEL | 2 |